← Back to Vaccine Database

MVA-EBNA1/LMP2 vaccine

Live attenuated vaccine · VDDBV0528

Target & Classification

EBVEpstein-Barr virus
Live attenuated vaccine
Epstein-Barr Virus Infections
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials4

NCT IDPhaseDisease / Condition
NCT01147991 Phase 1Epstein-Barr Virus Infections
NCT01094405 Phase 2Epstein-Barr Virus Infections
NCT01256853 Phase 1Epstein-Barr Virus Infections
NCT01800071 Phase 1Epstein-Barr Virus Infections